Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B
<b>Background</b>/<b>Objectives</b>: Hemophilia B is a hereditary bleeding disorder due to the production of liver malfunctional factor IX (FIX). Gene therapy with viral vectors offers a cure. However, applications are limited due to pre-existing antibodies, eligibility for c...
Saved in:
Main Authors: | Brijesh Lohchania (Author), Porkizhi Arjunan (Author), Gokulnath Mahalingam (Author), Abinaya Dandapani (Author), Pankaj Taneja (Author), Srujan Marepally (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
by: Porkizhi Arjunan, et al.
Published: (2024) -
Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
by: Gokulnath Mahalingam, et al.
Published: (2022) -
Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
by: Chun-Yu Chen, et al.
Published: (2020) -
Liver lobe-specific hydrodynamic gene delivery to baboons: A preclinical trial for hemophilia gene therapy
by: Kenya Kamimura, et al.
Published: (2023) -
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy
by: Kelly Godbout, et al.
Published: (2022)